Article
iPSC technology-based regenerative medicine for kidney diseases.
Clinical and experimental nephrology - 1 Jun 2021
Osafune Kenji
Abstract excerpt
With few curative treatments for kidney diseases, increasing attention has been paid to regenerative medicine as a new therapeutic option. Recent progress in kidney regeneration using human-induced pluripotent stem cells (hiPSCs) is noteworthy. Based on the knowledge of kidney development, the directed differentiation of hiPSCs into two embryonic kidney progenitors, nephron progenitor cells (NPCs) and ureteric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
